en · de · es · fr · pt
sr9009-notes.peptides7250.com › Wiki › Sr9009 Identity And Mechanism — Explained

Sr9009 Identity And Mechanism — Explained

By Editorial Desk · published 2026-03-19 · last reviewed 2026-04-29 · Wiki

REV-ERB agonist comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-04-29. Numbers and descriptions here follow the published literature rather than marketing material.

SR9009 Identity and Mechanism

SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.

SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.

REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.

Analytical Detection and Laboratory Handling

Physicochemical behavior influences handling. SR9009 is described as a solid with limited aqueous solubility, so organic solvents such as dimethyl sulfoxide or ethanol are common in research stock solutions. Aqueous dilution can produce precipitates if the organic content is too low. Light, heat, and repeated freeze-thaw cycles may affect stability. Storage recommendations usually specify a desiccated freezer environment protected from light, but exact stability data depend on the formulation and matrix.

Detection in biological samples can be complicated by rapid metabolism and low circulating concentrations. Some studies report phase I and phase II metabolites, and analytical methods may need to target those species in addition to the parent compound. Immunoassays are not broadly available, so mass spectrometry remains the main confirmatory approach. For anti-doping testing, laboratories look for SR9009 and its metabolites using validated LC-MS methods. Open questions include how long metabolites remain detectable and how different routes of administration alter detection windows.

In laboratory settings, SR9009 is typically characterized by liquid chromatography–mass spectrometry (LC-MS) or high-performance liquid chromatography with ultraviolet detection (HPLC-UV). These methods can confirm identity and estimate purity, but they require reference standards for accurate quantification. Because SR9009 is not a licensed pharmaceutical, no harmonized pharmacopeial monograph exists. Laboratories often validate in-house methods for matrices such as plasma, urine, or cell culture media. Sample preparation may involve protein precipitation or liquid-liquid extraction before analysis.

Sr9009 at a glance

PropertyValueNotes
Common nameSR9009Also marketed informally as Stenabolic
Chemical classSynthetic REV-ERB agonistBinds REV-ERBα and REV-ERBβ
Molecular formulaC24H30ClN3O4SApproximate molecular weight 492 g/mol
CAS Registry Number1379686-30-2Identifier for the parent compound
Regulatory statusNot approved for human useProhibited in sport by WADA

Background and Mechanism

Preclinical reports describe effects on exercise endurance, mitochondrial content, and lipid profiles in rodents, but these findings come from specific experimental conditions. Many studies use high doses or delivery methods that may not translate directly to human use. SR9009 has been reported to have low oral bioavailability and a short half-life, which complicates interpretation of oral dosing studies. It is not established as safe or effective for any indication. Literature discussions often separate its pharmacological mechanism from unverified claims made in fitness and supplement markets.

SR9009 is a synthetic small molecule studied as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is not an approved medicine and has no established human therapeutic use. The compound appears in scientific literature as a tool for probing circadian and metabolic regulation. Online sellers often label it as a research chemical, sometimes using the nickname Stenabolic. Its chemical identity is distinct from selective androgen receptor modulators, stimulants, and peroxisome proliferator-activated receptor delta agonists. Researchers use it mainly in cell and animal experiments.

Related pages on this site

Background from the literature

Humankind gradually evolved from early members of the genus Homo—such as Homo habilis, who used simple stone tools—into anatomically modern humans as well as behaviourally modern humans by the Upper Paleolithic. During the end of the Paleolithic Age, specifically the Middle or Upper Paleolithic Age, humans began to produce the earliest works of art and to engage in religious or spiritual behavior such as burial and ritual. Conditions during the Paleolithic Age went through a set of glacial and interglacial periods in which the climate periodically fluctuated between warm and cool temperatures. By c. 50,000 – c. 40,000 BP, the first humans set foot in Australia. By c. 45,000 BP, humans lived at 61°N latitude in Europe. By c. 30,000 BP, Japan was reached, and by c. 27,000 BP humans were present in Siberia, above the Arctic Circle. By the end of the Upper Paleolithic Age humans had crossed Beringia and expanded throughout the Americas continents.

At one point, Israeli commandos boarded helicopters prepared to fly into Iraq, but the mission was called off after a phone call from US defense secretary Dick Cheney, reporting on the extent of coalition efforts to destroy Scuds and emphasizing that Israeli intervention could endanger US forces. In addition to the attacks on Israel, 47 Scud missiles were fired into Saudi Arabia, and one missile was fired at Bahrain and another at Qatar. The missiles were fired at both military and civilian targets. One Saudi civilian was killed, and 78 others were injured. No casualties were reported in Bahrain or Qatar. The Saudi government issued all its citizens and expatriates with gas masks in the event of Iraq using missiles with warheads containing chemical weapons. The government broadcast alerts and 'all clear' messages over television to warn citizens during Scud attacks. On 25 February 1991, a Scud missile hit a US Army barracks of the 14th Quartermaster Detachment, out of Greensburg, Pennsylvania, stationed in Dhahran, Saudi Arabia, killing 28 soldiers and injuring over 100. A subsequent investigation found that the assigned Patriot missile battery had failed to engage due to the loss of significance effect in the onboard computer's floating point calculations compounding over 100 hours of consecutive use, shifting the range gate position far enough to lose contact with the Scud during tracking action.

Because the ELISA can be performed to evaluate either the presence of antigen or the presence of antibody in a sample, it is a useful tool for determining serum antibody concentrations (such as with the HIV test or West Nile virus). It has also found applications in the food industry in detecting potential food allergens, such as milk, peanuts, walnuts, almonds, and eggs and as serological blood test for celiac disease. ELISA can also be used in toxicology as a rapid presumptive screen for certain classes of drugs.

== Function == The edited region contains a proposed heparin binding site and is also part of the recognition sequence for proteolytic cleavage. Heparin binding inhibits cell binding and cell adhesion functions of the protein. Cleavage which occurs at amino acid position 97 reduces heparin binding but modulates the growth stimulatory activity of the protein. Since the editing site occurs within this proposed heparin binding region the effects of editing may have implications for heparin binding and proteolytic cleavage and therefore have other affects downstream. Since the protein has been implicated in these processes it is believed editing might effect apoptosis, regulation of cell growth and angiogenesis.

Sources: en.wikipedia.org

Further detail

His government pushed to increase its use and the number of TCM-trained doctors and announced that students of TCM would no longer be required to pass examinations in Western medicine. Chinese scientists and researchers, however, expressed concern that TCM training and therapies would receive equal support with Western medicine. They also criticized a reduction in government testing and regulation of the production of TCMs, some of which were toxic. Government censors have removed Internet posts that question TCM. In 2020 Beijing drafted a local regulation outlawing criticism of TCM. According to Caixin, the regulation was later passed with the provision outlawing criticism of TCM removed. Traditional Chinese Medicine does not reflect ancient medical practice, instead being a modern selection from very diverse traditions, with "a minimal vestige of ideas and practices" having been retained from them.

Valens's successor, Theodosius I (r. 379–395), secured peace in the east by allowing the Goths to settle in Roman territory; he also twice intervened in the western half, defeating the usurpers Magnus Maximus and Eugenius in 388 and 394, respectively. He actively condemned paganism, confirmed the primacy of Nicene Orthodoxy over Arianism in the East, and established Christianity as the Roman state religion. He was the last emperor to rule both the western and eastern halves of the empire. After his death, the West was destabilised but the East thrived due to the civilian administrators who continued to hold power. Theodosius II (r. 408–450) largely left the rule of the East to officials such as Anthemius, who constructed the Theodosian Walls. Constantinople had now entrenched itself as the empire's capital. Aside from Constantinople's walls, Theodosius' reign was also marked by the compilation of the Codex Theodosianus and the theological dispute over Nestorianism (a doctrine later deemed heretical). His reign also saw the arrival of Attila's Huns, who ravaged the Balkans, leading to a large tribute being exacted from the eastern empire. Attila switched his attention to the rapidly-deteriorating western empire, and his people fractured after his death in 453. Later, Leo I (r. 457–474) failed in his 468 attempt to reconquer the West. The warlord Odoacer deposed Romulus Augustulus in 476 and after the assassination of his titular successor Julius Nepos in 480, abolished the office of western emperor.

=== Role in cell adhesion, extravasation, migration === Acting through several integrins and probably a few yet unknown other receptors Thy-1 mediates adhesion of leukocytes and monocytes to endothelial cells and fibroblasts, melanoma cells to endothelium, and thymocytes to thymic epithelium. Thy1 expression comes on when endothelial cells are activated. It has been shown to interact with the leukocyte integrin Mac1 (CD11b/CD18) and may play a role in leukocyte homing and recruitment.

This has been supported by several organizations, including the Multidisciplinary Association for Psychedelic Studies (MAPS), the Beckley Foundation, the Heffter Research Institute, and the Albert Hofmann Foundation, which exist to fund, encourage, and coordinate research into the medicinal and spiritual uses of LSD and related psychedelics. New clinical LSD experiments in humans started in 2009 for the first time in 35 years. As the drug is illegal in many areas of the world, potential medical uses have historically been difficult to study. Investigational uses of LSD include the treatment of alcoholism, anxiety, and depression, among other conditions. Another use is alleviation of anxiety in terminally ill cancer patients. A single dose of LSD may temporarily reduce alcohol abuse and some psychiatric symptoms, but evidence is limited and unreliable due to methodological flaws and unclear causation. In 2024, the FDA designated a form of LSD as a breakthrough therapy to treat generalized anxiety disorder which is being developed by MindMed. A study published by the Journal of the American Medical Association in September, 2025 explored the optimal dose of LSD to lower patients' anxiety. The study was conducted by the pharmaceutical company MindMed. The researchers compared how LSD doses of 25 μg, 50 μg, 100 μg, 200 μg, or placebo impacted anxiety scores among study participants. The results of the study found that 100 μg was the optimal dose to reduce anxiety among the studied patients.

, raise and lower the energy level of each of the system's three modes (modified cyclotron, magnetron, and axial respectively), just like the raising and lowering operators from the quantum simple harmonic oscillator. These obey the commutation relations

Sources: en.wikipedia.org

Background from the literature

ERP (Enterprise Resource Planning): Delivering full-lifecycle services from consulting and deployment to operations and optimization, the company promotes its 'AX on ERP' strategy, embedding Agentic AI to automate corporate business processes. It continues to strengthen its strategic partnership with SAP, showcasing its ERP capabilities annually at 'SAP Sapphire' since 2024. In 2025, LG CNS became the first South Korean company to join SAP’s Regional Strategic Services Partner (RSSP) initiative for the Asia-Pacific region. PerfecTwin: A test automation system based on live transaction data validation technology. By accurately replicating live business context within simulated environments, it verifies systems before deployment to ensure transaction quality and stability. LG Optapex: A global marketing technology platform driven by artificial intelligence (AI) and mathematical optimization algorithms. Tailored for the Amazon e-commerce ecosystem, it automates advertising operations, including 24/7 automated bidding, budget allocation, and performance forecasting. By integrating product-level data such as profit margins, fees, shipping costs, and inventory levels, the platform maximizes seller profitability in real time. AX (AI Transformation): LG CNS delivers enterprise-grade services driven by generative AI and Agentic AI. The company applies AI technologies across diverse industry sectors, including manufacturing, finance, public services, defense, and pharmaceuticals. It operates its proprietary platform, 'AgenticWorks', to assist enterprises in adopting AI agents.

In 1911, there were three primary schools for every ten villages in British India. Early literacy was low: It was 5% in 1891 (9% for men and 1% for women) and 7% in 1921 (12% for men and 2% for women). Historically, local diversity limited literacy growth in India because caste and religious fragmentation reduced private spending. Literacy rates rose to 18% in 1951 (27% for men and 9% for women) and 41% in 1981 (53% for men and 29% for women). By 2011, literacy reached 74.04% (82.14% for men and 65.46% for women). They ranged from Kerala's 93.91% to Bihar's 63.82%. Meanwhile, rural gains reached twice the level of urban, narrowing the rural-urban gap from 21.2 percentage points in 2001 to 16.1 in 2011. The central, state, and local governments manage education in India. Every child between the ages of 6 and 14 has a right to education, which is free and compulsory. Traditionally, children had spent eight years in primary school before moving on to high school. In 2020, the National Education Policy changed this division to one based on developmental stages: a foundational stage: five years of pre-school and standards 1–2, for ages 3–8; a preparatory stage: standards 3–5; a middle stage: standards 6–8; and a secondary stage: standards 9–12. Critics argue that the new plan, although progressive, suffers from public underfunding and inadequate school infrastructure. The first universities in India were founded in Calcutta, Bombay, and Madras in 1857, the last year of East India Company rule. India now has one of the world's largest post-secondary education systems.

== Family == The Hoffmann-La Roche family is Switzerland's richest and one of the most secretive families. Many members of the family don't carry the last name Hoffmann anymore. Some are known as Oeri, Michalski, Faber-Castell, Fabre, Schmid or Duschmalé.

C(OH)-N that crosslinked its backbone amide groups, forming a two-dimensional fabric. Other primary structures of proteins were proposed by various researchers, such as the diketopiperazine model of Emil Abderhalden and the pyrrol/piperidine model of Troensegaard in 1942. Although never given much credence, these alternative models were finally disproved when Frederick Sanger successfully sequenced insulin and by the crystallographic determination of myoglobin and hemoglobin by Max Perutz and John Kendrew.

=== Pharmacokinetics === Azapirones are poorly but nonetheless appreciably absorbed and have a rapid onset of action, but have only very short half-lives ranging from 1–3 hours. As a result, they must be administered 2–3 times a day. The only exception to this rule is umespirone, which has a very long duration with a single dose lasting as long as 23 hours. Unfortunately, umespirone has not been commercialized. Although never commercially produced, Bristol-Myers Squibb applied for a patent on October 28, 1993, and received the patent on July 11, 1995, for an extended release formulation of buspirone. An extended release formulation of gepirone is currently under development and if approved, should help to improve this issue. Metabolism of azapirones occurs in the liver and they are excreted in urine and feces. A common metabolite of several azapirones including buspirone, gepirone, ipsapirone, revospirone, and tandospirone is 1-(2-pyrimidinyl)piperazine (1-PP). 1-PP possesses 5-HT1A partial agonist and α2-adrenergic antagonist actions and likely contributes overall mostly to side effects.

Sources: en.wikipedia.org

Frequently asked questions

What is SR9009?

SR9009 is a synthetic research compound that binds and modulates the nuclear receptors REV-ERBα and REV-ERBβ. It is used in laboratory studies of circadian biology and metabolism, not as an approved medicine. It is also known by the informal name Stenabolic.

Is SR9009 approved for human use?

No. SR9009 has not been approved as a therapeutic drug in the United States, European Union, or other major markets. Human safety and efficacy data are very limited. Its presence in consumer products does not imply regulatory approval.

Why is SR9009 banned in sport?

The World Anti-Doping Agency lists SR9009 as a prohibited substance because it can alter gene expression and metabolic pathways relevant to performance. The ban applies at all times, not only during competition. Detection relies on laboratory methods such as mass spectrometry.

How is SR9009 detected?

It is usually detected by LC-MS or HPLC-UV against a reference standard. In biological matrices, metabolite targeting can improve detection. No universal immunoassay is widely available.

Network